Tevogen, Inc. is a clinical-stage specialty immunotherapy company, which engages in the provision of off-the-shelf therapies for the treatment of infectious diseases, cancers, and neurological disorders. It focuses on its product, ExacTcell, a technology that treats acute viral infections, long-term consequences of viral infections, and viral and non-viral induced cancers. The company was founded in April 2021 and is headquartered in Warren, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
18
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Tevogen Inc. market cap is $432.68M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Tevogen Inc. 52 week high is $24.91 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Tevogen Inc. 52 week low is $3.64 as of November 21, 2026.
Tevogen Inc. stock price today is $5.90.
Tevogen Inc. stock price yesterday was $6.30.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Tevogen Inc.'s P/E ratio is -1.03.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Tevogen Inc. P/B ratio is -4.7491.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Tevogen Inc. 50-day moving average is $6.64.